Medical Care
Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Research Report 2025
- Mar 11, 25
- ID: 77984
- Pages: 99
- Figures: 97
- Views: 21
The global market for Sleeplessness and Circadian Rhythm Disorder Treatment was valued at US$ 909 million in the year 2024 and is projected to reach a revised size of US$ 1191 million by 2031, growing at a CAGR of 4.0% during the forecast period.
Sleeplessness, also known as insomnia, and circadian rhythm disorders are two common sleep-related issues that can significantly impact an individual"s quality of life. The treatment approaches for these conditions vary and can include a combination of lifestyle changes, behavioral interventions, and medical therapies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sleeplessness and Circadian Rhythm Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleeplessness and Circadian Rhythm Disorder Treatment.
The Sleeplessness and Circadian Rhythm Disorder Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sleeplessness and Circadian Rhythm Disorder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sleeplessness and Circadian Rhythm Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lanaform
Compass Health Brands (Carex Health)
Compumedics
Natus Medical
Teva Pharmaceuticals
Lucimed (Luminette)
Garmin
Koninklijke Philips
Mylan
Fitbit
Takeda Pharmaceutical
F.Hoffman La-Roche AG
Merck & Co. Inc.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Sumitomo Dainippon Pharma Co., Ltd
Vanda Pharmaceuticals, Inc.
Segment by Type
Drug Therapy
Light Therapy
Segment by Application
Hospital
Specialist Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sleeplessness and Circadian Rhythm Disorder Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Sleeplessness, also known as insomnia, and circadian rhythm disorders are two common sleep-related issues that can significantly impact an individual"s quality of life. The treatment approaches for these conditions vary and can include a combination of lifestyle changes, behavioral interventions, and medical therapies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sleeplessness and Circadian Rhythm Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleeplessness and Circadian Rhythm Disorder Treatment.
The Sleeplessness and Circadian Rhythm Disorder Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sleeplessness and Circadian Rhythm Disorder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sleeplessness and Circadian Rhythm Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lanaform
Compass Health Brands (Carex Health)
Compumedics
Natus Medical
Teva Pharmaceuticals
Lucimed (Luminette)
Garmin
Koninklijke Philips
Mylan
Fitbit
Takeda Pharmaceutical
F.Hoffman La-Roche AG
Merck & Co. Inc.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Sumitomo Dainippon Pharma Co., Ltd
Vanda Pharmaceuticals, Inc.
Segment by Type
Drug Therapy
Light Therapy
Segment by Application
Hospital
Specialist Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sleeplessness and Circadian Rhythm Disorder Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug Therapy
1.2.3 Light Therapy
1.3 Market by Application
1.3.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Perspective (2020-2031)
2.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Growth Trends by Region
2.2.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Region (2020-2025)
2.2.3 Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Region (2026-2031)
2.3 Sleeplessness and Circadian Rhythm Disorder Treatment Market Dynamics
2.3.1 Sleeplessness and Circadian Rhythm Disorder Treatment Industry Trends
2.3.2 Sleeplessness and Circadian Rhythm Disorder Treatment Market Drivers
2.3.3 Sleeplessness and Circadian Rhythm Disorder Treatment Market Challenges
2.3.4 Sleeplessness and Circadian Rhythm Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Revenue
3.1.1 Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Revenue (2020-2025)
3.1.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue
3.4 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Concentration Ratio
3.4.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in 2024
3.5 Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment Head office and Area Served
3.6 Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Product and Application
3.7 Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sleeplessness and Circadian Rhythm Disorder Treatment Breakdown Data by Type
4.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Type (2020-2025)
4.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Type (2026-2031)
5 Sleeplessness and Circadian Rhythm Disorder Treatment Breakdown Data by Application
5.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Application (2020-2025)
5.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2020-2031)
6.2 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025)
6.4 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2020-2031)
7.2 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025)
7.4 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2020-2031)
8.2 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2020-2031)
9.2 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025)
9.4 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2020-2031)
10.2 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lanaform
11.1.1 Lanaform Company Details
11.1.2 Lanaform Business Overview
11.1.3 Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.1.4 Lanaform Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.1.5 Lanaform Recent Development
11.2 Compass Health Brands (Carex Health)
11.2.1 Compass Health Brands (Carex Health) Company Details
11.2.2 Compass Health Brands (Carex Health) Business Overview
11.2.3 Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.2.4 Compass Health Brands (Carex Health) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.2.5 Compass Health Brands (Carex Health) Recent Development
11.3 Compumedics
11.3.1 Compumedics Company Details
11.3.2 Compumedics Business Overview
11.3.3 Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.3.4 Compumedics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.3.5 Compumedics Recent Development
11.4 Natus Medical
11.4.1 Natus Medical Company Details
11.4.2 Natus Medical Business Overview
11.4.3 Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.4.4 Natus Medical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.4.5 Natus Medical Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.5.4 Teva Pharmaceuticals Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Lucimed (Luminette)
11.6.1 Lucimed (Luminette) Company Details
11.6.2 Lucimed (Luminette) Business Overview
11.6.3 Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.6.4 Lucimed (Luminette) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.6.5 Lucimed (Luminette) Recent Development
11.7 Garmin
11.7.1 Garmin Company Details
11.7.2 Garmin Business Overview
11.7.3 Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.7.4 Garmin Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.7.5 Garmin Recent Development
11.8 Koninklijke Philips
11.8.1 Koninklijke Philips Company Details
11.8.2 Koninklijke Philips Business Overview
11.8.3 Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.8.4 Koninklijke Philips Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.8.5 Koninklijke Philips Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.9.4 Mylan Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.9.5 Mylan Recent Development
11.10 Fitbit
11.10.1 Fitbit Company Details
11.10.2 Fitbit Business Overview
11.10.3 Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.10.4 Fitbit Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.10.5 Fitbit Recent Development
11.11 Takeda Pharmaceutical
11.11.1 Takeda Pharmaceutical Company Details
11.11.2 Takeda Pharmaceutical Business Overview
11.11.3 Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.11.4 Takeda Pharmaceutical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.11.5 Takeda Pharmaceutical Recent Development
11.12 F.Hoffman La-Roche AG
11.12.1 F.Hoffman La-Roche AG Company Details
11.12.2 F.Hoffman La-Roche AG Business Overview
11.12.3 F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.12.4 F.Hoffman La-Roche AG Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.12.5 F.Hoffman La-Roche AG Recent Development
11.13 Merck & Co. Inc.
11.13.1 Merck & Co. Inc. Company Details
11.13.2 Merck & Co. Inc. Business Overview
11.13.3 Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.13.4 Merck & Co. Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.13.5 Merck & Co. Inc. Recent Development
11.14 Pfizer, Inc.
11.14.1 Pfizer, Inc. Company Details
11.14.2 Pfizer, Inc. Business Overview
11.14.3 Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.14.4 Pfizer, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.14.5 Pfizer, Inc. Recent Development
11.15 Pernix Therapeutics
11.15.1 Pernix Therapeutics Company Details
11.15.2 Pernix Therapeutics Business Overview
11.15.3 Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.15.4 Pernix Therapeutics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.15.5 Pernix Therapeutics Recent Development
11.16 Sanofi S.A.
11.16.1 Sanofi S.A. Company Details
11.16.2 Sanofi S.A. Business Overview
11.16.3 Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.16.4 Sanofi S.A. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.16.5 Sanofi S.A. Recent Development
11.17 Sumitomo Dainippon Pharma Co., Ltd
11.17.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
11.17.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.17.3 Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.17.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.17.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
11.18 Vanda Pharmaceuticals, Inc.
11.18.1 Vanda Pharmaceuticals, Inc. Company Details
11.18.2 Vanda Pharmaceuticals, Inc. Business Overview
11.18.3 Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.18.4 Vanda Pharmaceuticals, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.18.5 Vanda Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug Therapy
1.2.3 Light Therapy
1.3 Market by Application
1.3.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Perspective (2020-2031)
2.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Growth Trends by Region
2.2.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Region (2020-2025)
2.2.3 Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Region (2026-2031)
2.3 Sleeplessness and Circadian Rhythm Disorder Treatment Market Dynamics
2.3.1 Sleeplessness and Circadian Rhythm Disorder Treatment Industry Trends
2.3.2 Sleeplessness and Circadian Rhythm Disorder Treatment Market Drivers
2.3.3 Sleeplessness and Circadian Rhythm Disorder Treatment Market Challenges
2.3.4 Sleeplessness and Circadian Rhythm Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Revenue
3.1.1 Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Revenue (2020-2025)
3.1.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue
3.4 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Concentration Ratio
3.4.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in 2024
3.5 Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment Head office and Area Served
3.6 Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Product and Application
3.7 Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sleeplessness and Circadian Rhythm Disorder Treatment Breakdown Data by Type
4.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Type (2020-2025)
4.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Type (2026-2031)
5 Sleeplessness and Circadian Rhythm Disorder Treatment Breakdown Data by Application
5.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Application (2020-2025)
5.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2020-2031)
6.2 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025)
6.4 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2020-2031)
7.2 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025)
7.4 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2020-2031)
8.2 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2020-2031)
9.2 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025)
9.4 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2020-2031)
10.2 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lanaform
11.1.1 Lanaform Company Details
11.1.2 Lanaform Business Overview
11.1.3 Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.1.4 Lanaform Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.1.5 Lanaform Recent Development
11.2 Compass Health Brands (Carex Health)
11.2.1 Compass Health Brands (Carex Health) Company Details
11.2.2 Compass Health Brands (Carex Health) Business Overview
11.2.3 Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.2.4 Compass Health Brands (Carex Health) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.2.5 Compass Health Brands (Carex Health) Recent Development
11.3 Compumedics
11.3.1 Compumedics Company Details
11.3.2 Compumedics Business Overview
11.3.3 Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.3.4 Compumedics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.3.5 Compumedics Recent Development
11.4 Natus Medical
11.4.1 Natus Medical Company Details
11.4.2 Natus Medical Business Overview
11.4.3 Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.4.4 Natus Medical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.4.5 Natus Medical Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.5.4 Teva Pharmaceuticals Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Lucimed (Luminette)
11.6.1 Lucimed (Luminette) Company Details
11.6.2 Lucimed (Luminette) Business Overview
11.6.3 Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.6.4 Lucimed (Luminette) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.6.5 Lucimed (Luminette) Recent Development
11.7 Garmin
11.7.1 Garmin Company Details
11.7.2 Garmin Business Overview
11.7.3 Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.7.4 Garmin Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.7.5 Garmin Recent Development
11.8 Koninklijke Philips
11.8.1 Koninklijke Philips Company Details
11.8.2 Koninklijke Philips Business Overview
11.8.3 Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.8.4 Koninklijke Philips Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.8.5 Koninklijke Philips Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.9.4 Mylan Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.9.5 Mylan Recent Development
11.10 Fitbit
11.10.1 Fitbit Company Details
11.10.2 Fitbit Business Overview
11.10.3 Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.10.4 Fitbit Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.10.5 Fitbit Recent Development
11.11 Takeda Pharmaceutical
11.11.1 Takeda Pharmaceutical Company Details
11.11.2 Takeda Pharmaceutical Business Overview
11.11.3 Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.11.4 Takeda Pharmaceutical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.11.5 Takeda Pharmaceutical Recent Development
11.12 F.Hoffman La-Roche AG
11.12.1 F.Hoffman La-Roche AG Company Details
11.12.2 F.Hoffman La-Roche AG Business Overview
11.12.3 F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.12.4 F.Hoffman La-Roche AG Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.12.5 F.Hoffman La-Roche AG Recent Development
11.13 Merck & Co. Inc.
11.13.1 Merck & Co. Inc. Company Details
11.13.2 Merck & Co. Inc. Business Overview
11.13.3 Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.13.4 Merck & Co. Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.13.5 Merck & Co. Inc. Recent Development
11.14 Pfizer, Inc.
11.14.1 Pfizer, Inc. Company Details
11.14.2 Pfizer, Inc. Business Overview
11.14.3 Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.14.4 Pfizer, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.14.5 Pfizer, Inc. Recent Development
11.15 Pernix Therapeutics
11.15.1 Pernix Therapeutics Company Details
11.15.2 Pernix Therapeutics Business Overview
11.15.3 Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.15.4 Pernix Therapeutics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.15.5 Pernix Therapeutics Recent Development
11.16 Sanofi S.A.
11.16.1 Sanofi S.A. Company Details
11.16.2 Sanofi S.A. Business Overview
11.16.3 Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.16.4 Sanofi S.A. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.16.5 Sanofi S.A. Recent Development
11.17 Sumitomo Dainippon Pharma Co., Ltd
11.17.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
11.17.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.17.3 Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.17.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.17.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
11.18 Vanda Pharmaceuticals, Inc.
11.18.1 Vanda Pharmaceuticals, Inc. Company Details
11.18.2 Vanda Pharmaceuticals, Inc. Business Overview
11.18.3 Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.18.4 Vanda Pharmaceuticals, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
11.18.5 Vanda Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drug Therapy
Table 3. Key Players of Light Therapy
Table 4. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2020-2025)
Table 8. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2026-2031)
Table 10. Sleeplessness and Circadian Rhythm Disorder Treatment Market Trends
Table 11. Sleeplessness and Circadian Rhythm Disorder Treatment Market Drivers
Table 12. Sleeplessness and Circadian Rhythm Disorder Treatment Market Challenges
Table 13. Sleeplessness and Circadian Rhythm Disorder Treatment Market Restraints
Table 14. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Players (2020-2025)
Table 16. Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment as of 2024)
Table 17. Ranking of Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Headquarters and Area Served
Table 20. Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Product and Application
Table 21. Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Lanaform Company Details
Table 47. Lanaform Business Overview
Table 48. Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 49. Lanaform Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 50. Lanaform Recent Development
Table 51. Compass Health Brands (Carex Health) Company Details
Table 52. Compass Health Brands (Carex Health) Business Overview
Table 53. Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 54. Compass Health Brands (Carex Health) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 55. Compass Health Brands (Carex Health) Recent Development
Table 56. Compumedics Company Details
Table 57. Compumedics Business Overview
Table 58. Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 59. Compumedics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 60. Compumedics Recent Development
Table 61. Natus Medical Company Details
Table 62. Natus Medical Business Overview
Table 63. Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 64. Natus Medical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 65. Natus Medical Recent Development
Table 66. Teva Pharmaceuticals Company Details
Table 67. Teva Pharmaceuticals Business Overview
Table 68. Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 69. Teva Pharmaceuticals Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 70. Teva Pharmaceuticals Recent Development
Table 71. Lucimed (Luminette) Company Details
Table 72. Lucimed (Luminette) Business Overview
Table 73. Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 74. Lucimed (Luminette) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 75. Lucimed (Luminette) Recent Development
Table 76. Garmin Company Details
Table 77. Garmin Business Overview
Table 78. Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 79. Garmin Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 80. Garmin Recent Development
Table 81. Koninklijke Philips Company Details
Table 82. Koninklijke Philips Business Overview
Table 83. Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 84. Koninklijke Philips Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 85. Koninklijke Philips Recent Development
Table 86. Mylan Company Details
Table 87. Mylan Business Overview
Table 88. Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 89. Mylan Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 90. Mylan Recent Development
Table 91. Fitbit Company Details
Table 92. Fitbit Business Overview
Table 93. Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 94. Fitbit Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 95. Fitbit Recent Development
Table 96. Takeda Pharmaceutical Company Details
Table 97. Takeda Pharmaceutical Business Overview
Table 98. Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 99. Takeda Pharmaceutical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 100. Takeda Pharmaceutical Recent Development
Table 101. F.Hoffman La-Roche AG Company Details
Table 102. F.Hoffman La-Roche AG Business Overview
Table 103. F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 104. F.Hoffman La-Roche AG Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 105. F.Hoffman La-Roche AG Recent Development
Table 106. Merck & Co. Inc. Company Details
Table 107. Merck & Co. Inc. Business Overview
Table 108. Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 109. Merck & Co. Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 110. Merck & Co. Inc. Recent Development
Table 111. Pfizer, Inc. Company Details
Table 112. Pfizer, Inc. Business Overview
Table 113. Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 114. Pfizer, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 115. Pfizer, Inc. Recent Development
Table 116. Pernix Therapeutics Company Details
Table 117. Pernix Therapeutics Business Overview
Table 118. Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 119. Pernix Therapeutics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 120. Pernix Therapeutics Recent Development
Table 121. Sanofi S.A. Company Details
Table 122. Sanofi S.A. Business Overview
Table 123. Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 124. Sanofi S.A. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 125. Sanofi S.A. Recent Development
Table 126. Sumitomo Dainippon Pharma Co., Ltd Company Details
Table 127. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 128. Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 129. Sumitomo Dainippon Pharma Co., Ltd Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 130. Sumitomo Dainippon Pharma Co., Ltd Recent Development
Table 131. Vanda Pharmaceuticals, Inc. Company Details
Table 132. Vanda Pharmaceuticals, Inc. Business Overview
Table 133. Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 134. Vanda Pharmaceuticals, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 135. Vanda Pharmaceuticals, Inc. Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Sleeplessness and Circadian Rhythm Disorder Treatment Picture
Figure 2. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type: 2024 VS 2031
Figure 4. Drug Therapy Features
Figure 5. Light Therapy Features
Figure 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Specialist Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Sleeplessness and Circadian Rhythm Disorder Treatment Report Years Considered
Figure 12. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Players in 2024
Figure 16. Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in 2024
Figure 18. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2020-2031)
Figure 20. United States Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2020-2031)
Figure 24. Germany Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2020-2031)
Figure 32. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Lanaform Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 48. Compass Health Brands (Carex Health) Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 49. Compumedics Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 50. Natus Medical Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 51. Teva Pharmaceuticals Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 52. Lucimed (Luminette) Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 53. Garmin Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 54. Koninklijke Philips Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 55. Mylan Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 56. Fitbit Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 57. Takeda Pharmaceutical Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 58. F.Hoffman La-Roche AG Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 59. Merck & Co. Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 60. Pfizer, Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 61. Pernix Therapeutics Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 62. Sanofi S.A. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 63. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 64. Vanda Pharmaceuticals, Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drug Therapy
Table 3. Key Players of Light Therapy
Table 4. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2020-2025)
Table 8. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2026-2031)
Table 10. Sleeplessness and Circadian Rhythm Disorder Treatment Market Trends
Table 11. Sleeplessness and Circadian Rhythm Disorder Treatment Market Drivers
Table 12. Sleeplessness and Circadian Rhythm Disorder Treatment Market Challenges
Table 13. Sleeplessness and Circadian Rhythm Disorder Treatment Market Restraints
Table 14. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Players (2020-2025)
Table 16. Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment as of 2024)
Table 17. Ranking of Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Headquarters and Area Served
Table 20. Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Product and Application
Table 21. Global Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Lanaform Company Details
Table 47. Lanaform Business Overview
Table 48. Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 49. Lanaform Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 50. Lanaform Recent Development
Table 51. Compass Health Brands (Carex Health) Company Details
Table 52. Compass Health Brands (Carex Health) Business Overview
Table 53. Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 54. Compass Health Brands (Carex Health) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 55. Compass Health Brands (Carex Health) Recent Development
Table 56. Compumedics Company Details
Table 57. Compumedics Business Overview
Table 58. Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 59. Compumedics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 60. Compumedics Recent Development
Table 61. Natus Medical Company Details
Table 62. Natus Medical Business Overview
Table 63. Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 64. Natus Medical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 65. Natus Medical Recent Development
Table 66. Teva Pharmaceuticals Company Details
Table 67. Teva Pharmaceuticals Business Overview
Table 68. Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 69. Teva Pharmaceuticals Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 70. Teva Pharmaceuticals Recent Development
Table 71. Lucimed (Luminette) Company Details
Table 72. Lucimed (Luminette) Business Overview
Table 73. Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 74. Lucimed (Luminette) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 75. Lucimed (Luminette) Recent Development
Table 76. Garmin Company Details
Table 77. Garmin Business Overview
Table 78. Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 79. Garmin Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 80. Garmin Recent Development
Table 81. Koninklijke Philips Company Details
Table 82. Koninklijke Philips Business Overview
Table 83. Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 84. Koninklijke Philips Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 85. Koninklijke Philips Recent Development
Table 86. Mylan Company Details
Table 87. Mylan Business Overview
Table 88. Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 89. Mylan Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 90. Mylan Recent Development
Table 91. Fitbit Company Details
Table 92. Fitbit Business Overview
Table 93. Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 94. Fitbit Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 95. Fitbit Recent Development
Table 96. Takeda Pharmaceutical Company Details
Table 97. Takeda Pharmaceutical Business Overview
Table 98. Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 99. Takeda Pharmaceutical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 100. Takeda Pharmaceutical Recent Development
Table 101. F.Hoffman La-Roche AG Company Details
Table 102. F.Hoffman La-Roche AG Business Overview
Table 103. F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 104. F.Hoffman La-Roche AG Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 105. F.Hoffman La-Roche AG Recent Development
Table 106. Merck & Co. Inc. Company Details
Table 107. Merck & Co. Inc. Business Overview
Table 108. Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 109. Merck & Co. Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 110. Merck & Co. Inc. Recent Development
Table 111. Pfizer, Inc. Company Details
Table 112. Pfizer, Inc. Business Overview
Table 113. Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 114. Pfizer, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 115. Pfizer, Inc. Recent Development
Table 116. Pernix Therapeutics Company Details
Table 117. Pernix Therapeutics Business Overview
Table 118. Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 119. Pernix Therapeutics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 120. Pernix Therapeutics Recent Development
Table 121. Sanofi S.A. Company Details
Table 122. Sanofi S.A. Business Overview
Table 123. Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 124. Sanofi S.A. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 125. Sanofi S.A. Recent Development
Table 126. Sumitomo Dainippon Pharma Co., Ltd Company Details
Table 127. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 128. Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 129. Sumitomo Dainippon Pharma Co., Ltd Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 130. Sumitomo Dainippon Pharma Co., Ltd Recent Development
Table 131. Vanda Pharmaceuticals, Inc. Company Details
Table 132. Vanda Pharmaceuticals, Inc. Business Overview
Table 133. Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 134. Vanda Pharmaceuticals, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025) & (US$ Million)
Table 135. Vanda Pharmaceuticals, Inc. Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Sleeplessness and Circadian Rhythm Disorder Treatment Picture
Figure 2. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type: 2024 VS 2031
Figure 4. Drug Therapy Features
Figure 5. Light Therapy Features
Figure 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Specialist Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Sleeplessness and Circadian Rhythm Disorder Treatment Report Years Considered
Figure 12. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Players in 2024
Figure 16. Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in 2024
Figure 18. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2020-2031)
Figure 20. United States Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2020-2031)
Figure 24. Germany Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2020-2031)
Figure 32. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Lanaform Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 48. Compass Health Brands (Carex Health) Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 49. Compumedics Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 50. Natus Medical Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 51. Teva Pharmaceuticals Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 52. Lucimed (Luminette) Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 53. Garmin Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 54. Koninklijke Philips Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 55. Mylan Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 56. Fitbit Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 57. Takeda Pharmaceutical Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 58. F.Hoffman La-Roche AG Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 59. Merck & Co. Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 60. Pfizer, Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 61. Pernix Therapeutics Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 62. Sanofi S.A. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 63. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 64. Vanda Pharmaceuticals, Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232